International LIT Symposium 2024 “Synthetic Immunology / Synthetic Biology”
15.03.2024The International LIT Symposium takes place June 26th – 27th, 2024 in Regensburg, Germany.
News
The Institute generates news every day. Some findings are groundbreaking—some represent smaller steps. But ultimately, it is the combination of both that makes scientific advancement possible. Here is a little selection of the latest stories making it out to the wider world.
Showing
LIT Postdoctoral Scientist Dr. Jeremy Baldwin receives Fellowship by Joachim Herz Foundation
08.02.2024Dr. Jeremy Baldwin, Postdoctoral Scientist in the Functional Immune Cell Modulation Division of the LIT, received an Add-on Fellowships for Interdisciplinary Life Science of 12.500€ by the Joachim Herz Foundation for his research project on metabolically reprogramming CD8+ T cells for cancer immunotherapy applications.
Members of the German Bundestag visit the LIT
24.01.2024Peter Aumer and Katrin Staffler, members of the German Bundestag, visited the LIT on January 24, 2024.
Killer T Cells Support Tissue Regeneration
16.01.2024Researchers at the Leibniz Institute for Immunotherapy (LIT) have demonstrated that killer T cells of the immune system not only eliminate pathologically altered cells, but also promote the subsequent tissue wound healing process.
Professor Hendrik Poeck receives EU funding of 2 million euros
22.12.2023Professor Hendrik Poeck receives EU funding of 2 million euros for his research on immunotherapies in leukemia patients. The ERC Consolidator Grant will fund his research for a period of five years.
Scientific Director Prof. Philipp Beckhove speaks in German Bundestag
13.10.2023The Scientific Director of the Leibniz Institute for Immunotherapy (LIT), Prof. Philipp Beckhove, visited the German Bundestag. The attending deputies were impressed by the excellent research conducted at LIT. Subsequently, possibilities were discussed to enhance the international competitiveness of biomedical research in Germany.
Dr. Thomas Goppel, former Bavarian State Minister, visits the LIT
29.09.2023The former Bavarian State Minister for Science and the Arts, Dr. Thomas Goppel, and Ministerial Councilor Florian Albert visited on September 21, 2023, to get information about the latest developments in immunological research at LIT.
Regensburg Oncology Prize 2023 goes to LIT scientist Christian Schmidl
02.08.2023The award-winning work from Dr. Christian Schmidl’s group investigates epigenetic changes in tumor-infiltrating T cells that distinguish functional from dysfunctional (“exhausted”) T cells.
EIC awards €2.7M Pathfinder Open Grant to CAR T-REX Consortium to find better treatment for solid tumours
23.06.2023Partners in the international consortium CAR T-REX announce the awarding of a highly competitive EIC Pathfinder Open grant, following the positive evaluation of their project entitled ‘CAR T Cells Rewired to Prevent EXhaustion in the Tumour Microenvironment’.
Zimmermann Medal awarded to LIT scientist
23.06.2023The prestigious Johann Georg Zimmermann Medal was awarded this year to LIT scientist Prof. Hinrich Abken in recognition of his lifetime achievements.
